13th Global Pharmacovigilance and clinical trials summit

Start Date : March 28, 2019
End Date : March 29, 2019
Time : 10:00 am to5:00 pm

Phone : 4896666555
Email : globalpharmocovigilance2019@gmail.com

Description

With the excellent accomplishment of Pharmacovigilance Series of Conferences in the UK, the USA in back to back a long time in the course of the most recent quite a while which met with extraordinary accomplishment in Business Conferencing. It's happy to report thirteenth Global Pharmacovigilance and Drug Safety Summit amid March 28-29, 2019 Osaka, Japan with the topic ‘’Promulgating the prevention of adverse drug reaction". This is a 2-day Mega Event offering Exhibition, at the scene to grandstand the new and rising advancements with Keynote introduction, Oral, YRF (Student Presentation), blurb, e-publication Presentations.


 


 


We are happy to educate you that the Speaker/Delegate/Exhibitor openings are accessible at the meeting. kindly visit the website of the conference to find out about the scientific sessions and abstract submission, If needs to go to as Delegate, sympathetically enroll to the gathering. For any questions, mail us.


Participating Companies:


·         Abbvie,USA


·         E&Y, China


·         Salmanz Group, Australia


·         Nucleon Therapetics, India


·         Saudi Patient safety Center, Saudi


·         AlphaBeta Pharma, UK


·         King Abdullah Medical City (KAMC)


 


·         Takeda, USA

Registration Info

Follow the link: https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

Registration includes only registration

Package A includes registration + 2nights accommodation

Package B includes registration +3 nights accommodation

Contact the Organizer

Organized by

Organized by Zoey Williams

Zoey Williams ,
47 Churchfield Road, London.

Tel: 4896666555
Mobile: 4896666555
Email: globalpharmocovigilance2019@gmail.com
Website: https://www.conferenceseries.com/


Event Categories: Health & Nutrition.




Your Review

You must be logged in to post a comment.